Application 020564
- Type
- NDA
- Sponsor
- VIIV HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EPIVIR | LAMIVUDINE | TABLET;ORAL | 150MG | Yes | No |
| 003 | EPIVIR | LAMIVUDINE | TABLET;ORAL | 300MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020564-001 | EPIVIR | LAMIVUDINE | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 |
| N020564-003 | EPIVIR | LAMIVUDINE | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020564-001 | AB |
| N020564-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N020564-001 | EPIVIR | 150MG | TABLET / ORAL | AB | RLD | 1995-11-17 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020564-003 | EPIVIR | 300MG | TABLET / ORAL | AB | RLD, RS | 2002-06-24 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | N020564-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N020564-003 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020564-001 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020564-003 | AB | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020564-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N020564-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | 6bd6b9da-df69-46db-813e-4e7f3bdecf95 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Major Pharmaceuticals | 6fd4d6b9-65ea-4988-8d6f-dd220ec5052d | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Strides Pharma Science Limited | ac824c7e-9c9f-487b-ad2f-d50eaef5cbda | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Golden State Medical Supply, Inc. | f3637209-303e-4232-ae79-07315a990973 | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Apotex Corp. | 34c02bcc-d6ff-99d4-8e6a-4a91908adca8 | 2025-09-19 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Golden State Medical Supply, Inc. | 3c30216d-f9f5-104b-e063-6294a90af8fd | 2025-08-12 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Apotex Corp. | 87095352-c088-74b1-7be0-d3e293a90611 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Coupler LLC | 2d7db3b2-9b3c-3031-e063-6294a90a342c | 2025-02-06 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | e90671c6-7fff-48f4-8898-29f02d049c8b | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | 49d53e74-3798-4463-b817-1c8beb755034 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | American Health Packaging | 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Aurobindo Pharma Limited | a8a492ab-396a-4b7c-99b3-bcb6d3386f71 | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Rising Pharma Holdings, Inc. | bed2e227-8d36-40ea-bbbf-d8793bfda425 | 2024-04-16 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Aurobindo Pharma Limited | ba7ee31e-e8d4-4e17-b27a-d2ce69e3bb00 | 2024-04-16 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Lupin Pharmaceuticals, Inc. | ff3b5265-f533-4332-a861-d8c9c1664ffd | 2024-01-03 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Macleods Pharmaceuticals Limited | 1be30bcc-2d9f-4afc-8f09-adc840b3f2d9 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Ingenus Pharmaceuticals, LLC | 47f8be59-178c-4bad-96a4-a5c82784f308 | 2018-12-24 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 21695-367 | EPIVIR | lamivudine | Rebel Distributors Corp | NDA | Current |
| 49702-203 | EPIVIR | lamivudine | ViiV Healthcare Company | NDA | Current |
| 49702-203 | EPIVIR | lamivudine | ViiV Healthcare Company | NDA | Current |
| 49702-203 | EPIVIR | lamivudine | ViiV Healthcare Company | NDA | Current |
| 49702-203 | EPIVIR | lamivudine | ViiV Healthcare Company | NDA | Current |
| 49702-204 | EPIVIR | lamivudine | ViiV Healthcare Company | NDA | Current |
| 49702-204 | EPIVIR | lamivudine | ViiV Healthcare Company | NDA | Current |
| 49702-204 | EPIVIR | lamivudine | ViiV Healthcare Company | NDA | Current |
| 49702-204 | EPIVIR | lamivudine | ViiV Healthcare Company | NDA | Current |
| 50090-0550 | EPIVIR | lamivudine | A-S Medication Solutions | NDA | Current |
| 53808-0245 | EPIVIR | lamivudine | State of Florida DOH Central Pharmacy | NDA | Current |
| 53808-0246 | EPIVIR | lamivudine | State of Florida DOH Central Pharmacy | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 58707 | SUPPL | 2019-05-15 |
| 58682 | SUPPL | 2019-05-14 |
| 57663 | ORIG | 2019-02-15 |
| 54028 | SUPPL | 2018-05-07 |
| 53921 | SUPPL | 2018-05-01 |
| 50015 | SUPPL | 2017-10-12 |
| 2754 | SUPPL | 2016-07-22 |
| 34861 | SUPPL | 2016-07-21 |
| 34860 | SUPPL | 2015-10-07 |
| 25203 | SUPPL | 2015-10-02 |
| 34858 | SUPPL | 2015-04-14 |
| 2752 | SUPPL | 2015-03-26 |
| 2753 | SUPPL | 2015-02-24 |
| 34859 | SUPPL | 2015-02-20 |
| 34857 | SUPPL | 2011-12-02 |
| 25202 | SUPPL | 2011-11-22 |
| 34856 | SUPPL | 2008-02-14 |
| 2751 | SUPPL | 2008-02-07 |
| 41438 | SUPPL | 2007-09-26 |
| 41437 | SUPPL | 2007-09-26 |
| 41435 | SUPPL | 2007-09-26 |
| 20730 | SUPPL | 2007-09-26 |
| 2750 | SUPPL | 2006-10-31 |
| 34855 | SUPPL | 2006-10-26 |
| 25201 | SUPPL | 2006-06-20 |
| 34854 | SUPPL | 2006-06-14 |
| 41436 | SUPPL | 2005-01-06 |
| 12748 | SUPPL | 2004-12-03 |
| 2749 | SUPPL | 2004-12-02 |
| 34853 | SUPPL | 2004-10-04 |
| 25200 | SUPPL | 2004-10-04 |
| 12747 | SUPPL | 2003-12-02 |
| 25199 | SUPPL | 2003-11-25 |
| 25197 | SUPPL | 2002-10-08 |
| 12745 | SUPPL | 2002-10-08 |
| 25198 | SUPPL | 2002-06-24 |
| 12746 | SUPPL | 2002-06-24 |
| 2748 | SUPPL | 2002-03-01 |
| 25196 | SUPPL | 2001-03-06 |
| 51228 | SUPPL | 1900-01-01 |
| 51227 | SUPPL | 1900-01-01 |
| 51226 | SUPPL | 1900-01-01 |